South Korea reports over 300% increase in illegal weight-loss drug imports in H1 2026

South Korean customs authorities recorded a more than threefold increase in intercepted illegal imports of weight-loss medications during the first half of 2026. The surge highlights growing demand for GLP-1 agonists and related pharmaceuticals, though the specific origin of the illicit supply chains remains under investigation.